Comparison of McN-3495 [N-(1-methyl-2-pyrrolidinylidene)-N'-phenyl-1-pyrrolidinecarboximidamide], a new, orally effective, hypoglycemic agent, with the biguanides.
D000818:Animals; D001645:Biguanides / Q000494:pharmacology*; D001693:Biological Transport, Active / Q000187:drug effects; D001786:Blood Glucose / Q000378:metabolism; D002026:Buformin / Q000494:pharmacology*; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism; D004285:Dogs; D005260:Female; D005947:Glucose / Q000378:metabolism; D005951:Glucose Tolerance Test; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007408:Intestinal Absorption / Q000187:drug effects; D007773:Lactates / Q000097:blood; D008297:Male; D010629:Phenformin / Q000494:pharmacology*; D051381:Rats
D001645:Biguanides; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007773:Lactates; D010629:Phenformin; D005947:Glucose; D002026:Buformin